Your browser doesn't support javascript.
loading
Successful Treatment of Relapsed Acquired Amegakaryocytic Thrombocytopenia with Repeat Cyclosporine / 대한내과학회지
Korean Journal of Medicine ; : 258-261, 2016.
Article Dans Anglais | WPRIM | ID: wpr-36016
ABSTRACT
Acquired amegakaryocytic thrombocytopenia (AAMT) is an unusual disease characterized by severe thrombocytopenia resulting from a marked decrease in bone marrow megakaryocytes. Various pathogenic mechanisms have been suggested, and several treatments have been tried, with varying outcomes. In some case reports, cyclosporine and anti-thymocyte globulin have had good clinical results in the treat of AAMT. There are few reports on the treatment of relapsed AAMT with cyclosporine. We report a patient with relapsed AAMT who was treated successfully with an additional course of cyclosporine. The initial remission was achieved with cyclosporine 4 years earlier and a second remission was induced by cyclosporine. Cyclosporine may be effective for relapsed AAMT that previously responded to cyclosporine.
Sujets)

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Thrombopénie / Moelle osseuse / Mégacaryocytes / Ciclosporine / Sérum antilymphocyte Limites du sujet: Humains langue: Anglais Texte intégral: Korean Journal of Medicine Année: 2016 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Thrombopénie / Moelle osseuse / Mégacaryocytes / Ciclosporine / Sérum antilymphocyte Limites du sujet: Humains langue: Anglais Texte intégral: Korean Journal of Medicine Année: 2016 Type: Article